Navigation Links
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
Date:11/19/2009

122,061 ----- ----- ------ ------ ------- Loss from operations (4,527) (7,664) (15,443) (18,093) (117,658) Investment income 47 114 189 574 5,352 Interest expense (540) (52) (1,705) (90) (2,334) Other income (expense) 1,104 222 1,452 165 1,886 ----- --- ----- --- ----- Net loss $(3,916) $(7,380) $(15,507) $(17,444) $(112,754) ======= ======= ======== ======== ========= Basic and diluted net loss per common share $(1.34) $(2.54) $(5.29) $(6.07) ====== ====== ====== ====== Weighted- average shares used to compute basic and diluted net loss per common share 2,930,391 2,909,688 2,929,728 2,871,704 ========= ========= ========= ========= Pro forma basic and diluted net loss per common share $(0.33) $(0.52) $(1.14) $(1.21) ====== ====== ====== ====== Weighted- average pro forma shares used to compute pro forma basic and diluted net loss per share 14,444,897 14,301,745 14,422,465 14,263,761 ========== ========== ========== ========== OMEROS CORPORATION (A Development Stage Company) CONSOLIDATED BALANCE SHEETS (In thousands) September 30, December 31, 2009 2008 ---------- ---------- (unaudite
'/>"/>
SOURCE Omeros Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
2. Omeros Appoints David A. Mann to its Board of Directors
3. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
4. Omeros and BlueCrest Announce $20 Million Debt Facility
5. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
6. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
7. Omeros Appoints New Vice President of Clinical Development
8. Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery
9. Omeros Commences Initial Public Offering of Common Stock
10. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) ... the Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer ... programs on May 30 at 1:30 p.m. Eastern Time.  A ... available on the Investors page of the Cleveland BioLabs website ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 A ... effects of probiotics on athletes to find that those who ... percent longer. The results from the study showed that in ... Probiotic Action, known for their adult acne treatment ... acne, and how it may help their skin condition. ...
(Date:5/21/2013)... , May 22, 2013 First ... formulation of glycopyrronium bromide designed using Prosonix, particle engineering ... developing a portfolio of inhaled Respiratory Medicines by ... with PSX1002 that will assess its effect on lung ... in patients with moderate to severe chronic obstructive pulmonary ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
... in Second Pivotal Clinical Trial , WASHINGTON, Nov. ... today announced positive results from BLISS-76, the second of ... for treating systemic lupus. A full presentation of ... Annual Scientific meeting of the American College of Rheumatology. ...
... powder from her ring into wine glasses carelessly left unattended. ... holding a cabochon or faceted gemstone that can be broken ... so large it is rather odd nobody seems to notice ... the "smart capsule" devised in Younan Xia,s laboratory at ...
... DIEGO and INDIANAPOLIS, Oct. 30, 2009 Amylin Pharmaceuticals, Inc., ... LLY ) today announced that the U.S. Food and ... (exenatide) injection. BYETTA is now approved for use as a ... glycemic control in adults with type 2 diabetes. Previously, it ...
Cached Biology Technology:Promise of a New Lupus Treatment Is a Groundbreaking Achievement 2Promise of a New Lupus Treatment Is a Groundbreaking Achievement 3An exquisite container 2An exquisite container 3An exquisite container 4An exquisite container 5BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 2BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 3BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 4BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 5BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 6BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 7
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Do men's and women's hearts burn fuel differently? 2
... A&M Institute of Renewable Natural Resources have discovered fresh remains ... Texas, according to a research associate with the institute. ... individual of false spike "Quadrula mitchelli" with tissue still in ... alive in the San Saba River in ...
... at the Gladstone Institutes have gained new insight into the ... can prevent the normal development of stem cells in the ... cancer. "The news, being announced in a paper published ... the understanding of the role of stem cells in embryonic ...
... new research that could have implications for improving fertilization ... between individual sperm and eggs in red abalone, an ... models of these interactions. They are the first scientists ... natural habitat of the abalone in the laboratory, the ...
Cached Biology News:Researchers discover freshwater mussel species thought to be extinct 2Researchers discover freshwater mussel species thought to be extinct 3Researchers discover freshwater mussel species thought to be extinct 4Gladstone scientists offer new insight into the regulation of stem cells and cancer cells 2Gladstone scientists offer new insight into the regulation of stem cells and cancer cells 3UCLA life scientists' study of abalone yields new insights into sexual reproduction 2UCLA life scientists' study of abalone yields new insights into sexual reproduction 3UCLA life scientists' study of abalone yields new insights into sexual reproduction 4
Request Info...
ROCK-1 (cleaved) Monoclonal Ab 100 ug purified mouse monoclonal antibody. Clone# 12M03. Reacts with human. Tested in Western blot analysis....
Anti-Cullin-1 Host: rabbit polyclonal Species Reactivity: human, mouse Applications: IHC(P), WB, IP Storage: 4C...
Request Info...
Biology Products: